Roivant Sciences Ltd WT (ROIVW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ROIVW | ASBP | NGEN | ||
| Company | Roivant Sciences Ltd WT | Aspire Biopharma Holdings Inc | Nervgen Pharma Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.86 | 5.5000 | 3.80 | ||
| High | 2.92 | 6.3900 | 4.00 | ||
| Low | 2.75 | 4.9700 | 3.75 | ||
| Latest | 2.75 | 5.5200 | 3.83 | ||
| Change | -0.11 | -0.0300 | +0.08 | ||
| % Change | -3.85% | -0.54% | +2.13% | ||
| Volume | 37,800 | 249,600 | 298,000 | ||
| 20-Day Average Volume | 201,870 | 1,351,037 | 174,820 | ||
| Previous Close | 2.86 | 5.5500 | 3.75 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.78 | 8.4800 | 3.90 | ||
| 20-Day Raw Stochastic | 39.13% | 6.70% | 35.00% | ||
| 20-Day Relative Strength | 49.75 | 33.32 | 47.23 | ||
| Weighted Alpha | +210.22 | -89.70 | +4.53 | ||
| Today's Opinion | 48% Buy | 100% Sell | 32% Sell | ||
| Previous Opinion | 96% Buy | 100% Sell | 24% Sell | ||
| Last Month's Opinion | 88% Buy | 88% Sell | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.10% since 08/25/23 | -12.13% since 05/04/26 | +4.64% since 05/04/26 | ||
| Low | 2.75 on 09/01/23 | 3.3100 on 05/08/26 | 3.55 on 05/05/26 | ||
| High | 2.93 on 08/31/23 | 7.0500 on 05/07/26 | 4.00 on 05/11/26 | ||
| 1-Month | |||||
| %Chg | -15.12% since 08/01/23 | -82.64% since 04/10/26 | -5.43% since 04/10/26 | ||
| Low | 2.57 on 08/17/23 | 3.3100 on 05/08/26 | 3.55 on 05/05/26 | ||
| High | 3.21 on 08/02/23 | 36.3000 on 04/14/26 | 4.35 on 04/15/26 | ||
| 3-Month | |||||
| %Chg | +30.95% since 06/01/23 | -86.37% since 02/11/26 | -6.59% since 02/11/26 | ||
| Low | 1.92 on 06/27/23 | 3.3100 on 05/08/26 | 3.51 on 03/27/26 | ||
| High | 4.00 on 07/06/23 | 48.9000 on 02/17/26 | 4.67 on 04/07/26 | ||
| 6-Month | |||||
| %Chg | +59.88% since 03/01/23 | -96.04% since 11/11/25 | +58.66% since 11/11/25 | ||
| Low | 1.23 on 03/23/23 | 3.3100 on 05/08/26 | 2.31 on 11/18/25 | ||
| High | 4.00 on 07/06/23 | 205.2000 on 01/07/26 | 6.30 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | 929 | 0 | ||
| Shares Outstanding, K | N/A | 5,024 | 0 | ||
| Annual Sales | 29,050,000 | 10,000 | 46,920,000 | ||
| Annual Net Income | -171,980,000 | -24,480,000 | -38,100,000 | ||
| Last Quarter Sales | 1,999,000 | 0 | 0 | ||
| Last Quarter Net Income | -265,891,000 | -4,710,000 | -26,908,856 | ||
| 60-Month Beta | N/A | 0.21 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.60 on 11/14/25 | N/A | ||
| Earnings Date | 06/04/26 | 05/13/26 | 09/03/11 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | 0.00 | 0.00 | ||